Atherosclerosis is an inflammatory-fibrotic response to accumulation of cholesterol in the artery wall. In hypercholesterolemia, low density lipoproteins (LDL) accumulate and are oxidized to proinflammatory compounds in the arterial intima, leading to activation of endothelial cells, macrophages, and T lymphocytes. We have studied immune cell activation and the autoimmune response to oxidized LDL in atherosclerotic apo E-knockout mice. Autoantibodies to oxidized LDL exhibited subclass specificities indicative of T cell help, and the increase in antibody titers in peripheral blood was associated with increased numbers of cytokine-expressing T cells in the spleen. In addition to T cell-dependent antibodies, IgM antibodies to oxidized LDL were also increased in apo E-knockout mice. This suggests that both T cell-dependent and T cell-independent epitopes may be present on oxidized LDL. In moderate hypercholesterolemia, IgG antibodies were largely of the IgG2a isotype, suggesting that T cell help was provided by proinflammatory T helper (Th) 1 cells, which are prominent components of atherosclerotic lesions. In severe hypercholesterolemia induced by cholesterol feeding of apo E-knockout mice, a switch to Th2-dependent help was evident. It was associated with a loss of IFN-gamma-producing Th1 cells in the spleen, whereas IL-4-producing Th2 cells were more resistant to hypercholesterolemia. IFN-gamma but not IL-4 mRNA was detected in atherosclerotic lesions of moderately hypercholesterolemic apo E-knockout mice, but IL-4 mRNA appeared in the lesions when mice were made severely hypercholesterolemic by cholesterol feeding. These data show that IFN-gamma-producing Th1 cells infiltrate atherosclerotic lesions and provide T cell help for autoimmune responses to oxidized LDL in apo E-knockout mice. However, severe hypercholesterolemia is associated with a switch from Th1 to Th2, which results not only in the formation of IgG1 autoantibodies to oxidized LDL, but also in the appearance of Th2-type cytokines in the atherosclerotic lesions. Since the two subsets of T cells counteract each other, this switch may have important consequences for the inflammatory/immune process in atherosclerosis.
X Zhou, G Paulsson, S Stemme, G K Hansson
Title and authors | Publication | Year |
---|---|---|
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression
GN Fredrikson, L Andersson, I Söderberg, P Dimayuga, KY Chyu, PK Shah, J Nilsson |
Autoimmunity | 2005 |
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses
C Buono, CJ Binder, G Stavrakis, JL Witztum, LH Glimcher, AH Lichtman |
Proceedings of the National Academy of Sciences | 2005 |
Are Suppressors of Cytokine Signaling Proteins Recently Identified in Atherosclerosis Possible Therapeutic Targets?
J Tang, EW Raines |
Trends in Cardiovascular Medicine | 2005 |
Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice
S Potteaux, C Combadière, B Esposito, S Casanova, R Merval, P Ardouin, JL Gao, PM Murphy, A Tedgui, Z Mallat |
Molecular Medicine | 2005 |
The Absence of Platelet-Derived Growth Factor-B in Circulating Cells Promotes Immune and Inflammatory Responses in Atherosclerosis-Prone ApoE−/− Mice
J Tang, K Kozaki, AG Farr, PJ Martin, P Lindahl, C Betsholtz, EW Raines |
The American Journal of Pathology | 2005 |
Inflammation in coronary artery disease: potential role for immunomodulatory therapy
P Aukrust, A Yndestad, T Wæhre, L Gullestad, B Halvorsen, JK Damås |
Expert Review of Cardiovascular Therapy | 2005 |
Regulatory T cell responses: potential role in the control of atherosclerosis
Z Mallat, H Ait-Oufella, A Tedgui |
Current Opinion in Lipidology | 2005 |
Immunomodulation of atherosclerosis with a vaccine
PK Shah, KY Chyu, GN Fredrikson, J Nilsson |
Nature Clinical Practice Cardiovascular Medicine | 2005 |
Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (−/−) mice
KY Chyu, X Zhao, OS Reyes, SM Babbidge, PC Dimayuga, J Yano, B Cercek, GN Fredrikson, J Nilsson, PK Shah |
Biochemical and Biophysical Research Communications | 2005 |
Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells
K Rakesh, DK Agrawal |
International Immunopharmacology | 2005 |
Regulatory T cell responses: potential role in the control of atherosclerosis:
Z Mallat, H Ait-Oufella, A Tedgui |
Current Opinion in Lipidology | 2005 |
Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: Further evidence for the inflammatory basis of atherosclerosis
G Satterthwaite, SE Francis, K Suvarna, S Blakemore, C Ward, D Wallace, M Braddock, D Crossman |
American Heart Journal | 2005 |
Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases
E Magen, G Borkow, Z Bentwich, J Mishal, S Scharf |
Medical Hypotheses | 2005 |
Serum levels of interleukin-18 in patients with stable and unstable angina pectoris
R Rosso, A Roth, I Herz, H Miller, G Keren, J George |
International Journal of Cardiology | 2005 |
Bridging the innate and adaptive immune systems
GS Getz |
Journal of lipid research | 2005 |
Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC
JM Wilson, MS Petrik, MH Moghadasian, CA Shaw |
Canadian Journal of Physiology and Pharmacology | 2005 |
Antiatherogenic Effects of Dietary Plant Sterols Are Associated with Inhibition of Proinflammatory Cytokine Production in Apo E-KO Mice
B Nashed, B Yeganeh, KT HayGlass, MH Moghadasian |
The Journal of nutrition | 2005 |
Atherosclerosis: Diet and Drugs
A von Eckardstein |
2005 |